Literature DB >> 32058001

MRI T2 and T2* relaxometry to visualize neuromelanin in the dorsal substantia nigra pars compacta.

Hansol Lee1, Sun-Yong Baek2, Eun-Joo Kim3, Gi Yeong Huh4, Jae-Hyeok Lee5, HyungJoon Cho6.   

Abstract

Visualizing gradual changes in neuromelanin distribution within the substantia nigra is an important metric used to monitor the progression of Parkinsonism. This study aimed to identify the origin of the mismatch region between magnetic resonance transverse relaxation times (T2 and T2*) in the substantia nigra and investigate its feasibility and implications for in vivo detection of neuromelanin as a clinical biomarker. The relationships between neuromelanin distribution assessed by histological staining and the area of T2 and T2* mismatch determined by high- and low-resolution magnetic resonance relaxometry at 7T were directly compared in two normal and one depigmented substantia nigra collected at postmortem. In vivo feasibility of assessing T2 and T2* mismatch, clinically, was investigated using 3T magnetic resonance imaging. In the normal postmortem substantia nigra tissue, the T2 and T2* mismatch region exhibiting a linear pattern was strongly colocalized with neuromelanin distribution along the dorsal substantia nigra pars compacta, but a negligible amount of dorsal mismatch was observed in the depigmented brain. The regions of T2 and T2* mismatch from MRI, neuromelanin pigments from histology, and elevated iron signals from mass spectrometry were spatially overlapped for a normal postmortem brain. In preliminary in vivo studies, a similar, linear T2 and T2* mismatch region was observed in the dorsal area of the substantia nigra in eight normal subjects; this mismatch was significantly obscured in eight Parkinson's disease patients. The length of the dorsal linear mismatch line based on the T2*-T2 mask was significantly shorter in the Parkinson's disease patients compared to normal controls; this result was corroborated by reduced striatal uptake of [18F] FP-CIT dopamine transporters assessed by positron emission tomography scans. In conclusion, the measurement of T2 and T2* mismatch could serve as a complementary imaging biomarker to visualize the dorsal region of the substantia nigra pars compacta, which contains large amounts of neuromelanin.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depigmentation; Neuromelanin; Parkinson’s disease; Substantia nigra; Transverse magnetic resonance relaxometries

Mesh:

Substances:

Year:  2020        PMID: 32058001     DOI: 10.1016/j.neuroimage.2020.116625

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  5 in total

1.  Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.

Authors:  Claire O'Callaghan; Frank H Hezemans; Rong Ye; Catarina Rua; P Simon Jones; Alexander G Murley; Negin Holland; Ralf Regenthal; Kamen A Tsvetanov; Noham Wolpe; Roger A Barker; Caroline H Williams-Gray; Trevor W Robbins; Luca Passamonti; James B Rowe
Journal:  Brain       Date:  2021-09-04       Impact factor: 13.501

2.  Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.

Authors:  Hansol Lee; Myung Jun Lee; Eun-Joo Kim; Gi Yeong Huh; Jae-Hyeok Lee; HyungJoon Cho
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

Review 3.  Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.

Authors:  P Riederer; C Monoranu; S Strobel; T Iordache; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2021-10-12       Impact factor: 3.575

4.  Evaluation of the Swallow-Tail Sign and Correlations of Neuromelanin Signal with Susceptibility and Relaxations.

Authors:  Tzu-Wei Lee; Cheng-Yu Chen; Kuan Chen; Chao-Wei Tso; Hui-Hsien Lin; Ying-Liang Larry Lai; Fei-Ting Hsu; Hsiao-Wen Chung; Hua-Shan Liu
Journal:  Tomography       Date:  2021-03-27

5.  Unraveling the contributions to the neuromelanin-MRI contrast.

Authors:  Nikos Priovoulos; Stan C J van Boxel; Heidi I L Jacobs; Benedikt A Poser; Kamil Uludag; Frans R J Verhey; Dimo Ivanov
Journal:  Brain Struct Funct       Date:  2020-10-22       Impact factor: 3.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.